Utilizing Patient and Staff Voices to Promote Screening Practices among Perinatal Patients with Substance Use Histories
Main Article Content
Abstract
Objectives: National and international guidance recommends verbal screening to identify perinatal patients with substance use problems. However, perinatal patients report negative medical experiences and a rational fear of disclosing substance use due to negative consequences for disclosure. To improve screening experiences and accuracy, this study focused on the input of patients and staff with substance use disorders.
Methods: Participants were perinatal patients with substance use histories in a gender-specific treatment program (n=6) or staff (peer support specialists, paraprofessionals, or Qualified Providers) working with perinatal patients (n=14) in a gender-specific substance use disorder treatment program. Qualitative information was gathered in three ways: 1) focus groups with perinatal patients, 2) focus groups with paraprofessionals and QPs, and 3) three individual interviews were conducted. A descriptive phenomenological approach was used for analysis.
Results: The three themes that emerged from the perinatal patients with substance use histories group were provider fear of Child Protective Services (CPS), provider competency, and provider compassion. Three themes also emerged from the staff: methods to improve the assessment, concerns related to CPS, and challenges when working with healthcare professionals. Both groups recommended that (1) the screener’s introduction needs to provide information about CPS reporting, (2) patients receive a list of treatment resources, and (3) healthcare providers are trained in compassionate screening.
Discussion: Participants recommended that pregnant patients with substance use histories are more likely to share their substance use history if there is a sense of safety through compassionate care. Before screening, healthcare providers should be committed to seeking training to treat perinatal substance use, adopt stigma-free language, support autonomy to disclose substance use history due to previous encounters, and be transparent about the use of the information and outcome, and have treatment resources readily available to reduce the harms of mandatory reporting to CPS.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Wouldes, T. A., Crawford, A., Stevens, S., & Stasiak, K. (2021). Evidence for the Effectiveness and Acceptability of e-SBI or e-SBIRT in the Management of Alcohol and Illicit Substance Use in Pregnant and Post-partum Women. Frontiers in psychiatry, 12, 634805. https://doi.org/10.3389/fpsyt.2021.634805
3. Luong J, Board A, Gosdin L, et al. Alcohol Use, Screening, and Brief Intervention Among Pregnant Persons — 24 U.S. Jurisdictions, 2017 and 2019. MMWR Morb Mortal Wkly Rep 2023;72:55–62. DOI: http://dx.doi.org/10.15585/mmwr.mm7203a2
4. Ko JY, D’Angelo DV, Haight SC, et al. Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep 2020;69:897–903. DOI: http://dx.doi.org/10.15585/mmwr.mm6928a1
5. Wendell AD. Overview and epidemiology of substance abuse in pregnancy. Clin ObstetGynecol. 2013;56(1):91-96. doi:10.1097/GRF.0b013e31827feeb9
6. Zagorski N. Study Estimates 630K Infants Born With FASD Globally Each Year. Psychiatric news. 2017;52:1-1.
7. Denny CH, Acero CS, Terplan M, Kim SY. Trends in Alcohol Use Among Pregnant Women in the U.S., 2011–2018. American journal of preventive medicine. 2020;59:768-769.
8. Davis JM, MD, Jansson LM, MD, Jones HE, PhD. Prenatal Opioid Exposure: Have We Lost an Opportunity to Improve the Outcomes of Mothers and Their Infants? Clinical therapeutics. 2025.
9. Jilani SM, Jones HE, Grossman M, et al. Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate. The Journal of pediatrics. 2022;243:33-39.e1.
10. Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants. HHS Publication No. (SMA) 18–5054. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2018
11. Reese SE, Glover A, Fitch S, Salyer J, Lofgren V, McCracken Iii CT. Early Insights into Implementation of Universal Screening, Brief Intervention, and Referral to Treatment for Perinatal Substance Use. Matern Child Health J. 2023;27(Suppl 1):58-66. doi:10.1007/s10995-023-03842-x
12. Guille, C., Hall, C., King, C., Sujan, A., Brady, K., & Newman, R. (2022). Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people. Drug and Alcohol Dependence Reports, 3, 100064-100064. https://doi.org/10.1016/j.dadr.2022.100064
13. Martino S., Ondersma S.J., Forray A., Olmstead T.A., Gilstad-Hayden K., Howell H.B.,Yonkers K.A.: A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health. American Journal of Obstetrics & Gynecology 2018; 218: pp. 322.e1-322.e12.
14. Shogren, M. D., Harsell, C., & Heitkamp, T. (2017). Screening women for At‐Risk alcohol use: An introduction to screening, brief intervention, and referral to treatment (SBIRT) in women's health. Journal of Midwifery & Women's Health, 62(6), 746-754. https://doi.org/10.1111/jmwh.12659
15. Ko JY, Tong VT, Haight SC, et al. Obstetrician-gynecologists' practices and attitudes on substance use screening during pregnancy. J Perinatol. 2020; 40(3):422-432. doi:10.1038/s41372-019-0542-3
16. Baird GS, Lindo EG. Reducing the Harm of Urine Drug Screening in Pregnancy. JAMA Netw Open.2025;8(3):e250914. doi:10.1001/jamanetwo rkopen.2025.0914
17. Azimi V, Trammel C, Nacke L, et al. Racial equity in urine drug screening policies in labor and delivery. JAMA Netw Open. 2025;8(3):e250908. doi:10.1001/jamanetworkopen.2025.0908
18. Paltrow, L. M. (1990). When becoming pregnant is a crime. Criminal Justice Ethics, 9(1).
https://doi.org/10.1080/0731129X.1990.9991871
19. Flavin, J., & Paltrow, L. M. (2010). Punishing pregnant drug-using women: Defying law, medicine, and common sense. Journal of Addictive Diseases, 29(2), 231244. https://doi.org/10.1080/10550881003684830
20. Ferguson v. Charleston, 532 U.S. 67 (2001)
21. Biskupic, J., & The, W. P. (2011, Aug 01). Court to rule on pregnancy drug tests justices take up issue of hospitals providing results of screening to police: WASHINGTON - delving into the lingering controversy over crack babies,the supreme court said monday it would rule on whether public hospitals may test pregnant women for drug use and provide the results to police. Corpus Christi Caller – Times Retrieved from
http://libproxy.lib.unc.edu/login?url=https://www.proquest.com/newspapers/court-rule-on-pregnancy-drug-tests-justices-take/docview/2569405366/se-2
22. Faherty, L. J., Stein, B. D., & Terplan, M. (2020). Consensus Guidelines and State Policies: The Gap Between Principle and Practice at the Intersection of Substance Use and Pregnancy. American journal of obstetrics & gynecology MFM, 2(3), 100137. https://doi.org/10.1016/j.ajogmf.2020.100137
23. J os, P. H., Marshall, M. F., & Perlmutter, M. (1995). The Charleston policy on cocaine use during pregnancy: A cautionary tale. The Journal of Law, Medicine & Ethics, 23(2), 120-128.
https://doi.org/10.1111/j.1748-720X.1995.tb01341.x
24. Apsley, H. B., Brant, K., Brothers, S., Harrison, E., Skogseth, E., Schwartz, R. P., & Jones, A. A. (2024). Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them. Women's Health (London, England), 20, 17455057231224181. https://doi.org/10.1177/17455057231224181
25. Apsley, H. B., Vest, N., Knapp, K. S., Santos-Lozada, A., Gray, J., Hard, G., & Jones, A. A. (2023). Non-engagement in substance use treatment among women with an unmet need for treatment: A latent class analysis on multidimensional barriers. Drug and Alcohol Dependence, 242, 109715. https://doi.org/10.1016/j.drugalcdep.2022.109715
26. Ulrich M, Memmo EP, Cruz A, Heinz A, Iverson RE. Implementation of a Universal Screening Process for Substance Use in Pregnancy. Obstetrics and gynecology (New York. 1953). 2021;137:695-701
27. Glazer KB, Howell EA. A way forward in the maternal mortality crisis: addressing maternal health disparities and mental health. Arch Womens Ment Health. 2021;24(5):823–830.
28. Paris R, Herriott AL, Maru M, Hacking SE, Sommer AR. Secrecy Versus Disclosure: Women with substance use disorders share Experiences in Help Seeking During Pregnancy. Matern Child Health J. 2020;24(11):1396-1403. doi:10.1007/s10995-020-03006-1
29. Hilliard F, Goldstein E, Nervik K, Croes K, Ossorio PN, Zgierska AE. Voices of Women With Lived Experience of Substance Use During Pregnancy: A Qualitative Study of Motivators and Barriers to Recruitment and Retention in Research. Fam Community Health. 2023;46(1):1-12. doi:10.1097/FCH.0000000000000349
30. Meinhofer A, Witman A, Maclean JC, Bao Y. Prenatal substance use policies and newborn health. Health economics. 2022;31:1452-1467
31. Barber CM, Terplan M. Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective. Front Pediatr. 2023;11:1045745. Published 2023 May 24. doi:10.3389/fped.2023.1045745
32. Ashford RD, Brown AM, Curtis B. "Abusing addiction": our language still isn't good enough. Alcohol Treat Q. 2019;37(2):257-272. doi: 10.1080 /07347324.2018.151377
33. Puskar K, Gotham HJ, Terhorst L, et al. Effects of Screening, Brief Intervention, and Referral to Treatment (SBIRT) education and training on nursing students' attitudes toward working with patients who use alcohol and drugs. Substance abuse. 2013; 34:122
34. Jones, H. E., Hairston, E., Lensch, A. C., Marcus, L. K., & Heil, S. H. (2021). Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period. Preventive Medicine, 152(Pt 2), 106742-106742. https://doi.org/10.1016/j.ypmed.2021.106742
35. Lensch, A. C., Hairston, E., Carter, G., & Jones, H. E. (2022). Pregnant patients using opioids: Treatment access barriers in the age of COVID-19. Journal of Addiction Medicine, 16(1), E44-E47. https://doi.org/10.1097/ADM.0000000000000826